Skip header and navigation

9 records – page 1 of 1.

Date Research Question / Title Unique ID Research Team
April 21, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 RR EOC
April 1, 2021 What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? EOC210302 ESR EOC
January 22, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2 RR EOC
January 4, 2021 What are the differences in the clinical course of COVID-19 between patients undergoing chemotherapy and otherwise healthy individuals? [Update] EOC062201v2-01 ESR EOC
May 19, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901 RR Epidemiology & Modelling
May 12, 2020 What are the risk factors for severity and death associated with COVID-19? EPM050901-01 ESR Epidemiology & Modelling
May 6, 2020 What is the best evidence to guide the sequence or priority of re-opening each type of healthcare service and how have the closures impacted patients? EOC042202-02 ESR EOC
April 27, 2020 What is the best evidence to guide the sequence or priority of re-opening each type of healthcare service and how have the closures impacted patients? EOC042202 RR EOC
April 23, 2020 What is the best evidence to guide the sequence or priority of re-opening each type of healthcare service and how have the closures impacted patients? EOC042202-01 ESR EOC

9 records – page 1 of 1.